Factor VIII

Results: 143



#Item
51Reset Form  Please complete, print and submit. Coagulation Patient Information Sheet Instructions: To help provide the best possible service, supply the requested information below and send the paperwork with the specime

Reset Form Please complete, print and submit. Coagulation Patient Information Sheet Instructions: To help provide the best possible service, supply the requested information below and send the paperwork with the specime

Add to Reading List

Source URL: www.mayomedicallaboratories.com

Language: English - Date: 2014-12-01 17:11:30
522014 ASH Annual Meeting Special Scientific Symposium on RNA Therapeutics in Hematology RNAi Therapeutics for Hemophilia and Complement-Related Diseases Akin Akinc, PhD

2014 ASH Annual Meeting Special Scientific Symposium on RNA Therapeutics in Hematology RNAi Therapeutics for Hemophilia and Complement-Related Diseases Akin Akinc, PhD

Add to Reading List

Source URL: www.alnylam.com

Language: English - Date: 2014-12-08 15:55:27
53von_Willebrand_Disease.indd

von_Willebrand_Disease.indd

Add to Reading List

Source URL: www.mayomedicallaboratories.com

Language: English - Date: 2014-08-08 15:17:37
54Microsoft PowerPoint - HAE[removed]Figure 1 [Compatibility Mode]

Microsoft PowerPoint - HAE[removed]Figure 1 [Compatibility Mode]

Add to Reading List

Source URL: www.hemophilia.org

Language: English - Date: 2014-04-22 11:47:01
55Factor V deficiency: a concise review

Factor V deficiency: a concise review

Add to Reading List

Source URL: www.hemophilia.org

Language: English - Date: 2014-04-22 11:47:00
56Microsoft Word - Full Report Coagulation Factors September 2010

Microsoft Word - Full Report Coagulation Factors September 2010

Add to Reading List

Source URL: www.pipelinereview.com

Language: English - Date: 2010-09-08 05:47:02
57Summary Basis for Regulatory Action  Orphan Designation 22 October 2014 Natalya Ananyeva, PhD, Committee Chairperson

Summary Basis for Regulatory Action Orphan Designation 22 October 2014 Natalya Ananyeva, PhD, Committee Chairperson

Add to Reading List

Source URL: www.fda.gov

Language: English
58HIGHLIGHTS OF PRESCRIBING INFORMATION

HIGHLIGHTS OF PRESCRIBING INFORMATION

Add to Reading List

Source URL: www.fda.gov

Language: English
59RECOMBINATE [Antihemophilic Factor (Recombinant)] Lyophilized Powder for Reconstitution for injection Reconstitute with 10 mL of Sterile Water for Injection using Baxject II  DESCRIPTION

RECOMBINATE [Antihemophilic Factor (Recombinant)] Lyophilized Powder for Reconstitution for injection Reconstitute with 10 mL of Sterile Water for Injection using Baxject II DESCRIPTION

Add to Reading List

Source URL: www.fda.gov

Language: English
60RECOMBINATE [Antihemophilic Factor (Recombinant)] Lyophilized Powder for Reconstitution for injection Reconstitute with 5 mL of Sterile Water for Injection using Baxject II  DESCRIPTION

RECOMBINATE [Antihemophilic Factor (Recombinant)] Lyophilized Powder for Reconstitution for injection Reconstitute with 5 mL of Sterile Water for Injection using Baxject II DESCRIPTION

Add to Reading List

Source URL: www.fda.gov

Language: English